VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 361 filers reported holding VANECK VECTORS ETF TR in Q2 2016. The put-call ratio across all filers is 1.14 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $633,000 | +60.3% | 23,698 | +53.7% | 0.00% | +50.0% |
| Q2 2019 | $395,000 | +9.1% | 15,418 | -4.7% | 0.00% | 0.0% |
| Q1 2019 | $362,000 | +7.7% | 16,177 | +1.6% | 0.00% | 0.0% |
| Q4 2018 | $336,000 | +9.4% | 15,928 | -3.9% | 0.00% | 0.0% |
| Q3 2018 | $307,000 | -13.5% | 16,581 | +4.1% | 0.00% | 0.0% |
| Q2 2018 | $355,000 | +0.3% | 15,923 | -1.1% | 0.00% | 0.0% |
| Q1 2018 | $354,000 | -9.7% | 16,103 | -4.5% | 0.00% | 0.0% |
| Q4 2017 | $392,000 | -55.0% | 16,866 | -55.5% | 0.00% | -60.0% |
| Q3 2017 | $871,000 | +198.3% | 37,926 | +186.0% | 0.01% | +150.0% |
| Q2 2017 | $292,000 | -60.9% | 13,259 | -59.5% | 0.00% | -60.0% |
| Q1 2017 | $746,000 | +10.7% | 32,761 | +1.5% | 0.01% | +25.0% |
| Q4 2016 | $674,000 | +119.5% | 32,261 | +177.3% | 0.00% | +100.0% |
| Q3 2016 | $307,000 | -6.1% | 11,635 | -1.7% | 0.00% | 0.0% |
| Q2 2016 | $327,000 | – | 11,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |